Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Long-Term Investments (2019 - 2025)

IDEAYA Biosciences' Long-Term Investments history spans 7 years, with the latest figure at $410.3 million for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 1.1% year-over-year to $410.3 million; the TTM value through Dec 2025 reached $410.3 million, up 1.1%, while the annual FY2025 figure was $410.3 million, 1.1% up from the prior year.
  • Long-Term Investments for Q4 2025 was $410.3 million at IDEAYA Biosciences, up from $350.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $410.3 million in Q4 2025 and bottomed at $8.3 million in Q4 2022.
  • The 5-year median for Long-Term Investments is $121.3 million (2021), against an average of $181.3 million.
  • The largest annual shift saw Long-Term Investments tumbled 93.14% in 2022 before it surged 1966.75% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $121.3 million in 2021, then crashed by 93.14% to $8.3 million in 2022, then soared by 1192.44% to $107.5 million in 2023, then surged by 277.55% to $405.8 million in 2024, then increased by 1.1% to $410.3 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Long-Term Investments are $410.3 million (Q4 2025), $350.0 million (Q3 2025), and $322.1 million (Q2 2025).